[go: up one dir, main page]

TW200730468A - Methods for providing oxidatively stable ophthalmic compositions - Google Patents

Methods for providing oxidatively stable ophthalmic compositions

Info

Publication number
TW200730468A
TW200730468A TW095136125A TW95136125A TW200730468A TW 200730468 A TW200730468 A TW 200730468A TW 095136125 A TW095136125 A TW 095136125A TW 95136125 A TW95136125 A TW 95136125A TW 200730468 A TW200730468 A TW 200730468A
Authority
TW
Taiwan
Prior art keywords
methods
providing
ophthalmic compositions
oxidatively stable
stable ophthalmic
Prior art date
Application number
TW095136125A
Other languages
English (en)
Inventor
Azaam Alli
Shivkumar Mahadevan
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of TW200730468A publication Critical patent/TW200730468A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0036—Flash degasification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B01D19/0078—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042 by vibration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B01D7/02—Crystallisation directly from the vapour phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095136125A 2005-09-30 2006-09-29 Methods for providing oxidatively stable ophthalmic compositions TW200730468A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/241,313 US20070077303A1 (en) 2005-09-30 2005-09-30 Methods for providing oxidatively stable ophthalmic compositions

Publications (1)

Publication Number Publication Date
TW200730468A true TW200730468A (en) 2007-08-16

Family

ID=37619526

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095136125A TW200730468A (en) 2005-09-30 2006-09-29 Methods for providing oxidatively stable ophthalmic compositions

Country Status (11)

Country Link
US (2) US20070077303A1 (zh)
EP (1) EP1769834A3 (zh)
JP (1) JP2007099768A (zh)
KR (1) KR20070037415A (zh)
CN (1) CN1939278A (zh)
AR (1) AR057526A1 (zh)
AU (1) AU2006225174B2 (zh)
BR (1) BRPI0604723A (zh)
CA (1) CA2561676A1 (zh)
SG (1) SG131101A1 (zh)
TW (1) TW200730468A (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010143B1 (en) * 2006-03-17 2015-08-12 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
EP2004196B1 (en) 2006-03-31 2016-06-29 Vistakon Pharmaceuticals, LLC Ocular allergy treatments
WO2008151019A1 (en) * 2007-05-30 2008-12-11 University Of Florida Research Foundation, Inc. Extended release of bioactive molecules from silicone hydrogels
WO2011067791A2 (en) * 2009-12-03 2011-06-09 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
RU2578262C2 (ru) * 2011-08-31 2016-03-27 Джонсон Энд Джонсон Вижн Кэа, Инк. Жидкостные менисковые линзы с улучшенным составом на основе физиологического раствора
KR101703980B1 (ko) * 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
KR101919436B1 (ko) * 2015-05-28 2018-11-16 주식회사 삼양바이오팜 안정화된 약학 조성물 및 그의 제조방법
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
CN108686252B (zh) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639576A (en) * 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4931225A (en) * 1987-12-30 1990-06-05 Union Carbide Industrial Gases Technology Corporation Method and apparatus for dispersing a gas into a liquid
US4853088A (en) * 1988-04-12 1989-08-01 Marathon Oil Company Solar enhanced separation of volatile components from a liquid
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
JPH07286027A (ja) * 1994-04-19 1995-10-31 Hoya Corp 眼装着用レンズ材料及びそれを用いた眼装着用レンズ
US5597519A (en) * 1994-06-10 1997-01-28 Johnson & Johnson Vision Products, Inc. Ultraviolet cycling oven for polymerization of contact lenses
US5922249A (en) * 1995-12-08 1999-07-13 Novartis Ag Ophthalmic lens production process
JP3689900B2 (ja) * 1998-08-19 2005-08-31 ニプロ株式会社 医療用成形品
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20020037897A1 (en) * 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
AU2002345015A1 (en) * 2001-06-08 2002-12-23 Novartis Pharma Gmbh Ophthalmic once-a-day composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
DE20217473U1 (de) * 2002-11-11 2003-03-27 Analysen Service GmbH Umwelt- und Öllabor Leipzig, 04277 Leipzig Entgasungsmodul für Fluidproben
JP2005124809A (ja) * 2003-10-23 2005-05-19 Sanyo Chem Ind Ltd 医療用接着剤
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.

Also Published As

Publication number Publication date
JP2007099768A (ja) 2007-04-19
US20110201596A1 (en) 2011-08-18
SG131101A1 (en) 2007-04-26
CA2561676A1 (en) 2007-03-30
EP1769834A3 (en) 2009-10-07
CN1939278A (zh) 2007-04-04
BRPI0604723A (pt) 2007-08-28
KR20070037415A (ko) 2007-04-04
AR057526A1 (es) 2007-12-05
AU2006225174B2 (en) 2012-07-05
AU2006225174A1 (en) 2007-04-19
EP1769834A2 (en) 2007-04-04
US20070077303A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
MX2007006179A (es) Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
NO20073801L (no) Atineoplastiske kombinasjoner
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
EA031335B1 (ru) Производные пирролопиримидинов
MX342683B (es) Analogos de ciclopamina.
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
AU2010246102A8 (en) Pesticidal compositions
MX2009007146A (es) Conjugados porcion del factor ix-polimero que tienen ligadura que se puede liberar.
MXPA04008613A (es) N-aminoacetil-pirrolidina-2-carbonitrilos y su uso como inhibidores de ddp-iv.
WO2007085895A3 (en) Fap inhibitors
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
IL176142A (en) Processes for preparing montelukast sodium
TW200801027A (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
TW200720246A (en) Novel process for the preparation of acid chlorides
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TW200730468A (en) Methods for providing oxidatively stable ophthalmic compositions
PL1758852T3 (pl) Podstawione związki cyklopentenu
MX2009004991A (es) Derivados de monoacetato de ciclopenteno-diol.
MX2010008668A (es) Composiciones fungicidas que comprenden 3'-bromo-2,3,4,6'-tetramet oxy-2'-6-dimetilbenzofenona.
TW200728310A (en) Process for the preparation of ferri-succinylcasein